EUVIMEDEUVIMED entdecken
Crossref

Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study

Zachary Neubauer, Michael M Ong, Amit Singal, Shari R Lipner

Journal of the American Academy of Dermatology · 2025-12 · 93 (6) · 1612-1614

DOI: 10.1016/j.jaad.2025.08.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2025-12. Verfasst von Zachary Neubauer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

glucagon-like peptide-1 receptor agonisthair lossobesitytelogen effluviumweight loss

Autor:innen und Institutionen

  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • MD Program, Weill Cornell Medicine, New York, New York.
  • Rutgers New Jersey Medical School, Newark, New Jersey.
  • Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.

Zitieren

APA

Neubauer, Z., Ong, M. M., Singal, A., & Lipner, S. R. (2025). Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study. Journal of the American Academy of Dermatology, 93(6), 1612-1614. https://doi.org/10.1016/j.jaad.2025.08.033

Vancouver

Neubauer Z, Ong MM, Singal A, Lipner SR. Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study. Journal of the American Academy of Dermatology. 2025;93(6):1612-1614. doi:10.1016/j.jaad.2025.08.033

BibTeX
@article{Neubauer2025,
  author = {Neubauer, Zachary and Ong, Michael M and Singal, Amit and Lipner, Shari R},
  title = {Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2025},
  volume = {93},
  number = {6},
  pages = {1612--1614},
  doi = {10.1016/j.jaad.2025.08.033}
}
Kostenlos starten →